Biotechnology, Effectiveness, Smallpox, Vaccination, Vaccine, Health care

China approves Sinovac Biotech Covid-19 vaccine for general public use

On Feb 7, 2021
@BiotechSweden shared
RT @HealthyCarnivor: China approves Sinovac Biotech Covid-19 vaccine for general public use #BioTech via https://t.co/hmIoXfIspy https://t.co/LLbNQxb76Z
Open

The CoronaVac vaccine has already been given to key groups deemed to be at higher risk of exposure to the virus.. Read more at straitstimes.com.

www.straitstimes.com
On Feb 7, 2021
@BiotechSweden shared
RT @HealthyCarnivor: China approves Sinovac Biotech Covid-19 vaccine for general public use #BioTech via https://t.co/hmIoXfIspy https://t.co/LLbNQxb76Z
Open

China approves Sinovac Biotech Covid-19 vaccine for general public use

China approves Sinovac Biotech Covid-19 vaccine for general public use

The CoronaVac vaccine has already been given to key groups deemed to be at higher risk of exposure to the virus.. Read more at straitstimes.com.

China approves Sinovac Biotech COVID-19 vaccine for general public use

China approves Sinovac Biotech COVID-19 vaccine for general public use

Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical ...

China Approves Sinovac Biotech COVID-19 Vaccine

China Approves Sinovac Biotech COVID-19 Vaccine

It marks the second vaccine approved for public use in China. 

China Approves Sinovac Biotech Coronavirus Vaccine For General Public Use

China Approves Sinovac Biotech Coronavirus Vaccine For General Public Use

Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.

Shot in the dark: Early COVID-19 vaccine efficacy explained

Shot in the dark: Early COVID-19 vaccine efficacy explained

This week has seen a flurry of good news from COVID-19 vaccine developers, with Pfizer Inc. and BioNTech SE trumpeting early data indicating their mRNA candidate is more than 90% effective.

China approves its first COVID-19 vaccine

China approves its first COVID-19 vaccine

Chinese regulators granted a first approval for general use to a COVID-19 vaccine to China National Biotec Group’s (CNBG) BBIBP-CorV. “The NMPA granted conditional approval to the vaccine ...

Sinovac COVID-19 Vaccine Demonstrates Efficacy

Sinovac COVID-19 Vaccine Demonstrates Efficacy

Chinese company’s investigational vaccine reported to be 78% effective.

Sinovac's coronavirus vaccine candidate approved for emergency use in China - source

Sinovac's coronavirus vaccine candidate approved for emergency use in China - source

Sinovac Biotech Ltd's coronavirus vaccine candidate CoronaVac was approved in July for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a ...

China Focus: China approves inactivated COVID-19 vaccines for clinical trials

China Focus: China approves inactivated COVID-19 vaccines for clinical trials

BEIJING, April 14 (Xinhua) -- China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism ...

China Approves Sinovac Vaccine for Broad Use Against Covid-19

China Approves Sinovac Vaccine for Broad Use Against Covid-19

The country’s drug regulator has given provisional approval to a Covid-19 vaccine developed by Chinese drugmaker Sinovac Biotech, which has faced questions over its vaccine efficacy due to ...

Chinese COVID-19 vaccine far less effective than initially claimed in Brazil, sparking concerns

Chinese COVID-19 vaccine far less effective than initially claimed in Brazil, sparking concerns

A leading Chinese COVID-19 vaccine developed by Sinovac Biotech was just 50.38 per cent effective in late-stage trials in Brazil, significantly lower than earlier results showed, according ...

Chinese Covid-19 vaccine far less effective than initially claimed in Brazil, sparking concerns

Chinese Covid-19 vaccine far less effective than initially claimed in Brazil, sparking concerns

A leading Chinese Covid-19 vaccine developed by Sinovac Biotech was just 50.38% effective in late-stage trials in Brazil, significantly lower than earlier results showed, according to a ...

Experts Slam Bharat Biotech for Misleading Advisory on Covaxin Trials

Experts Slam Bharat Biotech for Misleading Advisory on Covaxin Trials

The document by the company said that it was “advisable” for recruits aged over 50  to participate in the trial as "it may take many months" before a government-approved vaccine is ...

Quick guide: COVID-19 vaccines in use and how they work

Quick guide: COVID-19 vaccines in use and how they work

Here's a quick guide to the COVID-19 vaccines now in use around the world.

EXPLAINER - Where are we in the COVID-19 vaccine race?

EXPLAINER - Where are we in the COVID-19 vaccine race?

Everything we know so far about the race to deliver vaccines to help end the coronavirus pandemic

Matching Sinopharm, fellow Chinese biotech Sinovac sees 78% COVID-19 vaccine efficacy

Matching Sinopharm, fellow Chinese biotech Sinovac sees 78% COVID-19 vaccine efficacy

A little over a week after Sinopharm nabbed the world’s first full approval from Chinese regulators on a 79% efficacy showing for its COVID-19 vax, fellow Chinese native Sinovac, using ...

China approves Sinovac’s coronavirus vaccine

China approves Sinovac’s coronavirus vaccine

China’s national regulator has approved Sinovac Biotech’s coronavirus vaccine for use by the general  public.

mRNA vaccines still lead the COVID-19 pack: Data Byte

mRNA vaccines still lead the COVID-19 pack: Data Byte

mRNA vaccines were the first to be authorized, and pivotal data show them to still be the most effective as a sixth COVID-19 vaccine reads out.

China's Sinovac plots pivotal COVID-19 vaccine trial in Brazil after positive phase 2

China's Sinovac plots pivotal COVID-19 vaccine trial in Brazil after positive phase 2

Another Chinese company is touting an early clinical win for its experimental COVID-19 vaccine. Two doses of Sinovac Biotech's COVID-19 vaccine candidate, dubbed CoronaVac, triggered an ...